A global perspective on developing a non-dietary treatment for coeliac disease

Join us for an overview of the current state of coeliac disease research, hear about the progress of Nexvax2® (the coeliac vaccine currently in clinical trials), and the objectives of ImmusanT, the company responsible for developing the vaccine. ...